The number of allogeneic haematopoietic cell transplantations (HCTs) continues to increase, with more than 50,000 HCTs performed annually worldwide. Allogeneic HCT from unrelated donors in the US has surpassed the number from related donors.
BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.
To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.
You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.
Use of this content is subject to our disclaimer